Weiping Yang
- Co-authors
- Qinghong QinQixing TanChangyuan WeiChenghong PengWeihua QiuQinguo MoZhi-Jie LiangJiqi Yan
- Topics
- Thyroid and Parathyroid Surgery (7 papers)Cancer-related Molecular Pathways (6 papers)Breast Cancer Treatment Studies (6 papers)
- Journals
- Nature CommunicationsSHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Weiping Yang
65 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 110
- Molecular Biology 626
- Cancer Research 446
- Oncology 301
- Surgery 265
- Pulmonary and Respiratory Medicine 190
Countries citing papers authored by Weiping Yang
This map shows the geographic impact of Weiping Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiping Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiping Yang more than expected).
Fields of papers citing papers by Weiping Yang
This network shows the impact of papers produced by Weiping Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiping Yang. The network helps show where Weiping Yang may publish in the future.
Co-authorship network of co-authors of Weiping Yang
This figure shows the co-authorship network connecting the top 25 collaborators of Weiping Yang. A scholar is included among the top collaborators of Weiping Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiping Yang. Weiping Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 56 | |
| 5 | 72 | |
| 6 | 18 | |
| 7 | 8 | |
| 8 | 3 | |
| 9 | 21 | |
| 10 | Prognostic value of hormone receptor status conversion following neoadjuvant chemotherapy in a series of operable breast cancer patients. | 14 |
| 11 | Prognostic value of Ki67 expression in HR-negative breast cancer before and after neoadjuvant chemotherapy. | 47 |
| 12 | 1 | |
| 13 | 52 | |
| 14 | 7 | |
| 15 | 8 | |
| 16 | 15 | |
| 17 | 6 | |
| 18 | 21 | |
| 19 | 41 | |
| 20 | The Study of Transferrin Receptor Gene Expression and Diagnosis of Hepatocellular Carcinoma by Monoclonal Antibody | 1 |
About Weiping Yang
Weiping Yang is a scholar working on Cancer Research, Transplantation and Oncology, having authored 68 papers that have together received 1.4k indexed citations. Recurring topics across this work include Thyroid and Parathyroid Surgery (7 papers), Cancer-related Molecular Pathways (6 papers) and Breast Cancer Treatment Studies (6 papers). The work is most often cited by research in Cancer Research (446 citations), Transplantation (40 citations) and Hepatology (93 citations). Weiping Yang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Qinghong Qin, Qixing Tan, Changyuan Wei, Chenghong Peng, Weihua Qiu, Qinguo Mo, Changyuan Wei, Zhi-Jie Liang, Jiqi Yan and Maojian Chen. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.